Your Page!

Shares of Citius jump 18%

Your Page!

Shares of Citius Pharmaceuticals Inc. CTXR, 0.82% were up 18.5% in premarket trading on Wednesday

Your Page!

After the company shared positive topline data from a Phase 3 clinical trial

Your Page!

 Treatment for cutaneous T-cell lymphoma

Your Page!

 Which is a type of non-Hodgkin lymphoma

Your Page!

Citius said it plans to submit an application for approval of the investigational therapy

Your Page!

Citius shares have soared 19.5% so far this year

Your Page!

 While the S&P 500 SPX, -1.20% is down 5.0%

Your Page!

These results reflect preliminary topline data and are subject to further analysis